Schol J, Wauters L, Dickman R et al (2021) United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
Dev Neurobiol 77(4):393
Inatomi Y, Ito T, Nagae K, Yamada Y, Kiyomatsu M, Nakano-Nakamura M, et al
The review also highlights the pharmacokinetic modifications developed to enhance the stability and efficacy of GLP-1 receptor agonists
GLP-1 and exendin-4 show a similar nM affinity while glucagon, secretin, VIP and GLP-2 have at least a hundred times lower affinity for the GLP-1 receptor
27 This randomized, placebo-controlled trial found a significant decrease in wound area after 3 months of treatment and a significant difference in wound-closure rate at week 12 (31% vs